Acidosis, not azotemla, stimulates branched-chain, amino acid catabolism in uremic rats. To investigate branched-chain, amino acid metabolism (BCAA) in muscle in chronic renal failure (CRF), we studied rats with moderately severe uremia (PUN 110 -mg/dl) and spontaneous metabolic acidosis (bicarbonate, 19 I mEq/liter). Plasma BCAA levels in CRF compared to pair-fed control rats were 15% lower and muscle valine was 93 tM lower (P < 0.05). BCAA metabolism was measured in incubated epitrochlearis muscles using L-[l-'4C]valine or L-[l-'4CJleucine in the presence and absence of insulin. BCAA decarboxylation was increased (P < 0.05) and insulin-stimulated BCAA incorporation into protein was blunted (P < 0.05) by CRF. Since we have found that metabolic acidosis, by itself, stimulates muscle branchedchain, ketoacid dehydrogenase activity, another group of CRF and control rats was given NaHCO3 which corrected the acidosis, but not the azotemia. BCAA decarboxylation in muscle was reduced in CRF rats given NaHCO3, and this was reflected in increased plasma and muscle BCAA concentrations. We conclude that in CRF, chronic To examine whether CRF changes BCAA metabolism in muscle, a model of moderately severe uremia was created in rats, and valine and leucine metabolism were measured. The model required a high protein diet in order to mimic the level of azotemia and the mild metabolic acidosis generally present in CRF patients. The importance of the spontaneous acidosis of CRF on BCAA metabolism was then evaluated in a second experiment by supplementing the diet of another group of CRF rats with sufficient sodium bicarbonate to correct their acidosis. The results establish that in CRF, metabolic acidosis contributes to abnormal BCAA metabolism by increasing oxidative decarboxylation of BCAA in skeletal muscle.
boxylation was increased (P < 0.05) and insulin-stimulated BCAA incorporation into protein was blunted (P < 0.05) by CRF. Since we have found that metabolic acidosis, by itself, stimulates muscle branchedchain, ketoacid dehydrogenase activity, another group of CRF and control rats was given NaHCO3 which corrected the acidosis, but not the azotemia. BCAA decarboxylation in muscle was reduced in CRF rats given NaHCO3, and this was reflected in increased plasma and muscle BCAA concentrations. We conclude that in CRF, chronic metabolic acidosis stimulates BCAA decarboxylation in skeletal muscle and this could contribute to the reduced intra-and extracellular concentrations of BCAA. Correction of acidosis should be a goal of therapy in CRF, especially when dietary regimens restrict intake of BCAA. The mechanism accounting for the low plasma levels of branched-chain amino acids (BCAA), and especially valine, in patients with chronic renal failure (CRF) is unknown [1] .
Possible explanations include inadequate dietary BCAA, malabsorption or excessive splanchnic BCAA degradation and/or increased BCAA catabolism in peripheral tissues. Regarding dietary deficiency, plasma BCAA concentrations in CRF patients were found to be subnormal, even when uremic and control subjects were eating diets identical in protein content [2] . Malabsorption or increased splanchnic disposal seem unlikely because BCAA release into hepatic venous blood is increased in CRF patients compared to normal subjects [3] .
These observations suggest that BCAA utilization in peripheral tissues must be increased by CRF. This hypothesis seems reasonable since a major portion of BCAA metabolism occurs extrahepatically [4] . BCAA are first transaminated and then irreversibly catabolized by the branched-chain, ketoacid dehydrogenase complex (BCKAD) [5, 6] , the rate-limiting reaction for BCAA degradation, at least in skeletal muscle [6] . The Received for publication August 14, 1986 and in revised form February 13 and May 4, 1987 © 1987 by the International Society of Nephrology hypothesis also is attractive because metabolic acidosis frequently accompanies CRF and we have found in non-azotemic rats that chronic metabolic acidosis, by itself, reduces plasma BCAA levels and increases their oxidative decarboxylation in muscle. The latter effect measured in vitro reflected stimulation of BCKAD activity in muscles freeze clamped in vivo [7] .
To examine whether CRF changes BCAA metabolism in muscle, a model of moderately severe uremia was created in rats, and valine and leucine metabolism were measured. The model required a high protein diet in order to mimic the level of azotemia and the mild metabolic acidosis generally present in CRF patients. The importance of the spontaneous acidosis of CRF on BCAA metabolism was then evaluated in a second experiment by supplementing the diet of another group of CRF rats with sufficient sodium bicarbonate to correct their acidosis. The results establish that in CRF, metabolic acidosis contributes to abnormal BCAA metabolism by increasing oxidative decarboxylation of BCAA in skeletal muscle.
Methods

Ani,nals
Male Sprague-Dawley rats weighing 75 to 100 g (Charles River Breeding Laboratory, Inc., Wilmington, Masachusetts, USA) were housed in temperature controlled quarters with a 12-hour lightll2-hour dark cycle, and given water and 14% protein chow (Agway Country Foods, Syracuse, New York, USA) ad libitum. After anesthesia with sodium pentobarbitol (5 mg/100 g body wt), approximately 5/6 of the left kidney was infarcted by ligating branches of the renal artery (CRF). One week later, a right nephrectomy was performed through a flank incision. At the same time, the right kidney of weight-matched control rats (SO) was exposed and manipulated through a flank incision, but not injured.
CRF and control rats were fed 14% protein for one week and then switched to a diet that produces normal growth in CRF rats [8] and pair-fed for 10 days. The diet contained 46% protein and consisted of casein, RMH 3000 chow (Agway Country Foods) and dextrin (40:35:25, wt/wt/wt). The food intake of each CRF rat (approximately 14 g per day) was used to determine the intake of its paired control rat. CRF and control rats were given 0.0375 M NaCI and water ad libitum, respectively. In another experiment, rats prepared similarly were pair-fed the diet supplemented with 1.7% sodium bicarbonate (CRF-HCO3 and SO-HCO3) to correct the acidosis associated with CRF [9] .
In vivo studies On the experimental day, rats were anesthetized, the anterior tibialis and epitrochlearis muscles were removed and aortic blood was obtained for blood gas analysis, plasma urea nitrogen (PUN) and BCAA concentrations. To measure BCAA concentrations, 100 d of plasma were deproteinized with an equal volume of 10% perchloric acid (PCA) and then 50 1d of 0.15 M sodium acetate (pH 4.9) containing fluorophenylalanine as the internal standard were added. The deproteinized plasma was neutralized with KOH and reconstituted to a final volume of 0.5 ml before assay. The anterior tibialis muscle was immediately homogenized in 1.5 ml of ice cold 5% PCA and centrifuged. Four hundred pi of supernatant were added to 200 1 of the sodium acetate buffer containing fluorophenylalanine. The mixture was neutralized with KOH, centrifuged and the supernatant was reconstituted with sodium acetate buffer to a final volume of 0.8 ml. Valine, leucine, and isoleucine concentrations in plasma and muscle homogenate samples were measured as the o-phthaldialdehyde derivatives by a high-performance liquid chromatography (HPLC) system (Waters Association, Milford, Massachusets, USA). Intracellular BCAA concentrations in muscle were calculated by subtracting plasma (extracellular) BCAA concentrations, using values for the extracellular space and water content determined previously [10, 111. convex gradient to 60% A/40% B at 1 ml/min over 3.2 minutes; c) linear gradient to 30% A!70% B at 1 mllmin over 16 minutes; d) 100% B isocratic at 1.3 ml/min over 5 minutes; e) linear gradient back to the initial solvent composition at 1.3 mllmin over 2 minutes. Samples were quantitated by comparison with known amounts of standards and concentrations were calculated using the internal standard.
In vitro studies The epitrochlearis muscles were blotted, weighed, and immediately placed in flasks containing 3 ml Krebs-Henseleit buffer, equilibrated with 95% 02/5% CO2 (pH 7.4). The preincubation media contained 10 m glucose and either 0.2 mM valine or 0.15 mM leucine. After 30 minutes of preincubation in a shaking water bath at 37°C, muscles were removed, blotted, transferred to flasks containing fresh media, with or without 1 mU/ml insulin, and regassed before incubating for a 2-hour experimental period.
In studies of valine metabolism, L-[l-'4C]valine (0.25 mCi/ mmol) was added to the experimental incubation media which contained 0.2 mri valine; in studies of leucine metabolism, L-[l-'4C]leucine (0.33 mCilmmol) was added to media which contained 0.15 m leucine. At the end of the experimental period, the flasks were placed on ice and 2 ml of media were transferred by syringe to another stoppered flask containing 0.5 ml of 50% trichloroacetic acid and a hanging center well with 0.2 ml phenethylamine to collect '4C02. After one hour of incubation at 37°C, the '4C02 trapped in the center well was measured by liquid scintillation counting with correction for quenching using an external standard. The 14C02 collected was divided by the intracellular specific radioactivity of the amino acid in order to calculate the rate of amino acid decarboxylation. This was done because we were unable to measure the intracellular specific radioactivity of the appropriate cl-ketoacid reliably, but others have shown that it is in equilibrium with that of the respective amino acid in rat skeletal muscle [121.
Stoppers with new center wells containing 0.2 ml of fresh phenethylamine were placed, 0.5 ml of 50% H202 were injected into the stoppered flasks, and they were incubated for an additional hour at 37°C to collect 14C02 liberated from decarboxylation of the [1-'4C]a-ketoacid [13] . The net rate of transamination was calculated as the sum of the rates of decarboxylation of the amino acid and ketoacid divided by the intracellular specific radioactivity of the amino acid. Radioactivity and the concentrations of valine and leucine in the acid-soluble fraction of the muscle homogenate were determined and used to calculate the specific radioactivity of the amino acid in intracellular fluid [7] . In this calculation, values for total tissue water and extracellular space of the epitrochlearis muscle determined previously [11] were used. The total acid soluble radioactivity was used for this calculation because earlier experiments [7] showed that the14CO2 evolved by decarboxylating the a-ketoacid present in the muscle supernatant with H202 [13] was less than 5% of the total radioactivity in the supernatant. Moreover, by analyzing the supernatant and the media, we found that the estimated intracellular £1-ketoacid was less than 5% of the total a-ketoacid in both compartments, Therefore, the net rate of transamination was calculated as the amount of l-14C-cx-ketoacid present in the media plus the '4C02 formed from the L[1-14C]amino acid during the experimental incubation divided by the intracellular specific radioactivity of the amino acid.
In an earlier study, epitrochlearis muscles from control rats were studied by the same methods. After the 30 minute preincubation, one muscle from each rat was incubated for 60 minutes and the contralateral muscle incubated for 120 minutes. Rates of net transamination and decarboxylation of l-'4C-valine were calculated based on the intracellular specific radioactivity measured at the end of each incubation period [71. Intracellular specific radioactivity measured at 60 minutes (618 17 DPM/ nmol valine) did not differ from that measured at 120 minutes (644 29 DPM/nmol valine). Moreover, the rates of decarboxylation at one hour were not statistically different (15.4 1.9, 1 hr, vs. 18.1 2.8 nmol/glhr, 2hr), making it likely that the specific radioactivity of the a-ketoacid was nearly constant.
There was a 16% decrease (P = NS) in net transamination in the second hour. This may mean that the intracellular BCAA specific radioactivity achieves equilibrium earlier than did its s-ketoacid, and to that extent, our method slightly overestimates net transamination.
Immediately after the medium was removed from the flasks, muscles were removed, washed in iced saline, blotted and homogenized in 1.5 ml 5% PCA. The protein precipitate was 
Statistics
Results are presented as mean SEM and values for each experiment were compared using Student's paired t-tests because the uremic and control rats were pair-fed and muscles from each pair were studied simultaneously. Results were considered significant at P < 0.05.
Results
One week following the right nephrectomy, we paired the rats as closely as possible according to weight. Although there was a small (P < 0.05) difference between the average weights of the CRF versus SO and CRF-HCO3 versus SO-HCO3 groups at this time, there was no difference in weights after the two-week pair-feeding period ( Table 1) . The blood pH and bicarbonate concentration and the PUN of CRF rats were significantly different from those of SO rats ( Table 1 ). The bicarbonate concentration calculated from the blood pH and pCO2 measured at the time of the experiment revealed that all CRF rats had a value <21 mEq/liter; the average value was 19 1 mEq/liter. Bicarbonate supplementation did not significantly change the PUN of CRF rats, but corrected the metabolic acidosis of CRF; it did not change the pH, blood bicarbonate or PUN of SO rats (Table 1) , BCAA concentrations in plasma and the intracellular fluid of muscle are presented in Table 2 . Plasma BCAA levels were 12 to 18% lower in CRF rats compared to their pair-fed controls, but these differences were not statistically significant. In muscles from CRF rats, intracellular valine was significantly reduced while leucine and isoleucine were unaffected (experiment 1, Table 2 ). The difference between CRF and SO rats suggests that the pools of valine, were decreased in uremic rats despite a protein intake identical to that of the appropriate control rat.
In the second pair-feeding experiment (experiment 2), the BCAA levels in both plasma and muscle of CRF-HCO3 rats were higher than in their pair-fed controls, suggesting that BCAA pools were higher. In both experiments, the intracellular valine concentration exceeded the plasma level, as has been reported by others in studies of non-uremic, fed rats [15] . The intra-to extracellular ratios of BCAA we found were similar to those reported [15] and did not differ significantly between uremic and control rats in either experiment ( Table 2 ). The high plasma BCAA concentrations compared to previous studies of amino acid levels in CRF rats [16, 17] reflect the fact that samples in the present study were obtained from fed rats eating a high-protein diet [181. We have no explanation for the finding that the valine level in muscle of SO-HCO3 rats was lower than that of SO rats. However, it is inadvisable to make comparisons between groups of rats in experiments 1 and 2 because each experiment was designed as a separate pair-feeding study, and the pattern of daily food intake varied in each experiment.
BCAA decarboxylation rates by incubated epitrochlearis muscles are presented in Figures 1 and 2 . Valine decarboxylation was threefold greater in muscles from CRF compared to control rats, both in the presence and absence of insulin (Fig.  1) . The higher valine decarboxylation rate cannot be attributed to an indirect stimulation of BCKAD activity by increased intracellular leucine in uremic rats [6, 19] , since intracellular levels of this amino acid measured before (Table 2) or at the end of the incubation period (Table 3) did not vary between the groups. In contrast, when acidosis, but not uremia (Table 1) , was prevented by giving uremic rats NaHCO3, valine decarboxylation was actually one-third lower than in muscles of control rats receiving the same amount of NaHCO3, though this difference was not statistically significant ( Figs. 1 and 2 ). Leucine decarboxylation also was increased in muscles of CRF compared to control rats (experiment 1), both in the presence and absence of insulin (Fig. 2) . As reported previously, leucine decarboxylation rates exceeded the rates for valine [6, 7, 12, 20] . This is probably due to an increase in the activity state of BCKAD associated with the higher intracellular leucine levels (Table 3) caused by incubating with leucine [9, 21, 22]. On the other hand, differences in intracellular leucine measured before the experiment or at the end of the incubation (Tables 2, 3 ) cannot explain the higher rate occurring in CRF compared to control muscles ( Table 2) . As with the valine decarboxylation measurements, when the metabolic acidosis of uremia was corrected (CRF-HCO3), leucine decarboxylation was slightly lower than in control (SO-HCO3) muscles. Leucine, like valine, decarboxylation was lower in the presence of insulin (Figs. 1, 2 ).
We confirmed (Table 4 ) that the rate of net BCAA transamination exceeds decarboxylation in skeletal muscle [5, 6, 7, 13, 19, 23] but, as noted (Methods) our measure of net transamination probably overestimates the in vivo rate. Net transamination rates for leucine or valine tended to be higher in CRF muscles compared to control, but the differences were not statistically significant. The net leucine transamination rate exceeded that of valine, perhaps because the Km for leucine of branched-chain, amino acid transaminase is lower than that for valine [6] . It is unclear why insulin had different effects on valine and leucine transamination. Since net transamination was measured as the sum of decarboxylation and a-ketoacid formation, a possible explanation is that insulin caused a greater decrease in leucine compared to valine decarboxylation (Figs.   1, 2) .
In experiment 1, the rates of valine and leucine incorporation into protein in the absence of insulin were lower in muscles of Values are man 5EM of muscles from at least 6 rats in each group. In Study A, valine decarboxylation was measured during a two hour incubation with 0. CRF compared to control rats; this was eliminated by feeding NaHCO3 in experiment 2. Incorporation of valine and leucine into protein was stimulated (P < 0.05) by insulin in muscles of all groups (Table 5 ). However, in muscles of individual rats, the increment in valine incorporation induced by insulin was less by paired analysis (P < 0.05) in both uremic groups compared to their respective controls. The same was true for leucine incorporation in muscles from CRF compared to SO rats. Although the rate of leucine incorporation exceeded that of valine, this may not represent a stimulation of protein synthesis by leucine [24, 25] because there is more leucine than valine in skeletal muscle protein [26] .
Discussion
In this study, we found that the intracellular valine level in muscle is depressed (Table 2) in rats with chronic uremia and a blood bicarbonate concentration <21 mEq/liter. In this respect, the model we studied reflects findings present in CRF patients [1] . Plasma BCAA levels tended to be lower in CRF rats, but the differences were not statistically significant. Since the lower intracellular valine concentration was not associated with an abnormal intra-to extracellular concentration gradient, the data suggest that the valine pool is low in CRF if it can be assumed that the distribution volume is unchanged. The lower intracellular valine concentration cannot be attributedto a difference in protein and hence valine intake, since the rats were pair-fed. Nor can the difference be attributed to uremia, per Se, since intracellular valine in muscles of CRF-HCO3 rats actually higher than that of SO-HCO3 rats, even though the degree of azotemia was the same in CRF and CRF-HCO3 rats (Table 1 ).
This suggests that the lowtr in vivo valine concentration in muscle of CRF rats was caused by increased decarboxylation. In fact, decarboxylation of valine and leucine was found to be accelerated in muscles of acidotic CRF rats (Figs. 1, 2 ).
Accelerated decarboxylation was due to the chronic metabolic acidosis of CRF, rather than azotemia, because decarboxylation rates in muscles from CRF-HCO3 rats were lower compared to those in pair-fed SO-HCO3 rats. Although the decarboxylation rates in muscles of CRF-HCO3 rats were not statistically lower compared to SO-HCO3 rats, this may be important because basal decarboxylation was 16% and 34% lower for leucine and valine, respectively, and the plasma and muscle levels in CRF-HCO3 rats were higher. These results suggest that azotemia by itself depresses BCAA decarboxylation. Although insulin reduced the decarboxylation of both leucine and valine in muscles from all groups, the stimulation of decarboxylation by CRF in experiment 1 persisted (Figs. 1, 2) . The mechanism by which insulin reduced BCAA decarboxylation is unknown. A similar observation was reported by Hutson et al in studies of fed, normal rats; the authors suggested that insulin decreased BCAA oxidation by inhibiting protein degradation and/or stimulating protein synthesis, leading to a reduced intracellular pool of branched-chain ketoacids available for decarboxylation [151. Thus, the in vitro decarboxylation measurements (Figs. 1, 2) are consistent with the in vivo BCAA concentrations (Table 2) , although one must be cautious in inferring in vivo BCAA decarboxylation rates from in vitro rates.
Previously, we found that in non-azotemic rats, chronic Values are mean raM of muscles from at least 6 rats in each group.
Media contained 0.2 mat valine or 0.15 Mm leucine. In each experiment, one muscle was incubated in media not containing insulin, and the contralateral muscle incubated in media supplemented with 0.2% albumin and 1 mU/ml insulin. Abbreviations are CRF, chronic renal failure; SO, sham-operated; CRF-HCO3 and SO-HCO3, chronic renal failure and sham-operated rats receiving supplemental sodium bicarbonate a P < 0.05 compared with control b P C 0.025 compared with basal conditions by paired i-test Values are mean sEat of muscles from at least 6 rats in each group.
Media contained 0.2 mM valine or 0.15 m leucine. In each experiment, one muscle was incubated in media not containing insulin, and the contralateral muscle incubated in media supplemented with 0.2% albumin and 1 mU/ml insulin. Abbreviations are: CRF, chronic renal failure; SO, sham-operated were 1.7%; CRF-HCO3 and SO-HCO3, rats receiving sodium bicarbonate in the diet a P < 0.05 compared with control "P C 0.001 by paired i-test compared with basal metabolic acidosis induced by feeding NH4C1 stimulates valine and leucine decarboxylation by increasing both the total amount of BCKAD in muscle and the percentage of BCKAD in the active form [7] . In rats with CRF, the degree of acidosis was less compared to this previous study, but the effect of acidosis on BCAA metabolism was similar. Thus, we conclude that oxidative decarboxylation of BCAA in muscle of CRF rats (Figs. 1, 2 ) was stimulated by the same mechanism as in acidotic, non-azotemic rats. Decarboxylation was returned to normal when acidosis, but not azotemia (Table 1) , was corrected. Because the rat has a high capacity to excrete acid, it was necessary to feed the CRF rats a high-protein diet in order to induce moderate azotemia and a mild metabolic acidosis.
Previous studies of rats have not shown that CRF causes decreased BCAA levels [16, 17] . In these reports, rats were fed lower amounts of protein, and this plus their capacity for acid excretion may have prevented metabolic acidosis. Unfortunately, the acid-base status of rats in these previous studies [16, 171 was not reported. Although dietary protein clearly affects BCAA levels [8] , the pair-feeding comparisons we used allowed us to isolate an important, independent effect of metabolic acidosis on BCAA metabolism. Potential mechanisms for the stimulation of BCKAD include increased intracellular a-ketoisocaproate and/or increased glucocorticoid production [6, 19, 21, 27] . Although the intracellular a-ketoisocaproate concentration could not be accurately measured, both intracellular leucine and the net rate of its transamination were virtually the same in muscles of CRF or SO rats (Tables 2, 3) . It seems unlikely, therefore, that a-ketoisocaproate caused the differences in BCAA decarboxylation we observed. A second mechanism for the increased BCAA decarboxylation in CRF might involve glucocorticoids since pharmacologic doses increase skeletal muscle BCKAD activity in normal rats [28] and in rats, glucocorticoid production is increased by acidosis [291. It is unlikely that this is the sole mechanism, however, since we also have found that corticosterone excretion is increased in rats with CRF, even when their acidosis is corrected by supplemental bicarbonate [9] . Since BCAA decarboxylation is not stimulated when muscles from normal rats are incubated in acidified media [7] , and since all muscles in the present study were incubated at pH 7.4, it appears that the acidosis must be chronic to cause a change in BCAA decarboxylation. Perhaps, both metabolic acidosis and increased glucocorticoid production are required to stimulate BCAA decarboxylation in CRF rats. This would be interesting because this combination accelerates protein degradation in muscle of non-uremic rats [29] .
A lower plasma and intracellular concentration of BCAA (and especially valine) in uremic humans implies that the pools of BCAA are depressed in uremia [1] . Smaller pools cannot be explained adequately by differences in protein intake [2] nor is there direct evidence for selective malabsorption of BCAA [3] . This leads to the conclusion that there is increased utilization of BCAA by peripheral tissues, principally liver and skeletal muscle. Although BCAA could be transaminated in peripheral tissues, with the resulting a-ketoacids decarboxylated in the liver, it seems unlikely that this is the major cause of low BCAA pools since plasma levels of branched-chain a-ketoacids are low in CRF patients [30, 31] . Moreover, splanchnic catabolism of branched-chain a-ketoacids must be reduced in uremia since oral administration of a-ketoisovalerate leads to a higher plasma level in CRF patients compared to normal subjects [32] , and orally administered a-ketoisocaproate is incorporated into nonsplanchnic protein with greater efficiency in uremic compared to control rats [33] . From the present data (Table 5 ) and our previous measurements of muscle protein synthesis in CRF, it seem unlikely that an increase in BCAA incorporation into muscle protein can account for the low BCAA pools in uremia. This leaves excessive catabolism of BCAA by muscle as the most likely explanation for the reduced BCAA pools in CRF.
There are reports suggesting that BCAA catabolism is not increased by CRF. Jones and Kopple infused 1-'4C-valine into five control and three uremic subjects eating a high-carbohydrate, low-protein diet and measured the rate of expired '4C02 after an overnight fast [2] . Valine decarboxylation was calculated using the plasma amino acid, specific radioactivity, and it was concluded that the rate of inrreversible loss of valine was reduced 28% in the uremic subjects. Recently, the accuracy of this calculation has been questioned [12] , since there are important differences between the plasma amino acid and intracellular a-ketoacid (the precursor pool for decarboxylation) specific radioactivities. Fortunately, the intracellular BCAA specific radioactivity (which we used) and that of the respective a-ketoacid are equal in muscle [12] . Epstein et al compared the '4C02 excretion rates of two uremic and two control subjects eating diets containing S g of protein plus an amino acid supplement in which a-ketoisovalerate was substituted for valine [34] . The decarboxylation of an oral load of [1-'4C]aketoisovalerate was calculated from the expired '4C02 and its specific radioactivity, and it was concluded that uremic and normal subjects did not differ [34] . Unfortunately, the acid-base status of patients in both of these studies was not presented. Thus, it is not clear that the present results can be extrapolated to humans.
Certain observations suggest that in muscle, BCAA metabolism and protein catabolism share common control mechanisms. In rats, both streptozotocin-induced diabetic ketoacidosis and NH4C1-induced acidosis are associated with increased protein catabolism and BCAA decarboxylation in skeletal muscle [7, 20, 29] . In CRF, nitrogen balance in humans [35] and nitrogen excretion in rats [9] is improved by administering sufficient NaHCO3 to correct the acidosis. SO-HCO3; P < 0.01). Although these data suggest that bicarbonate supplementation improved dietary protein utilization, we believe this conclusion is unwarranted because there was no difference in this ratio between SO and SO-HCO3 rats (0.37 0.02, 50 vs. 0.39 0.02, SO-HCO3). Furthermore, we have measured nitrogen intake and excretion in another study designed to assess the effects of metabolic acidosis on muscle protein metabolism in rats with CRF [9] . In that study, there was no significant difference in nitrogen balance between CRF-HCO3 and pair-fed SO-HCO3 rats. An alternative explanation for the greater weight gain of CRF-HCO3 rats would be linked to their higher sodium intake (-S 4.5 mEq Na/day) compared to the CRF group (-1.7 mEq Na/day). Our finding that in CRF, excessive BCAA catabolism and protein degradation in muscle are corrected by NaHCO3, suggests that protein and BCAA catabolism in muscle are linked. It is tempting to ascribe the accelerated muscle proteolysis of CRF to excessive leucine catabolism because leucine can stimulate muscle protein synthesis in vitro [24, 25] and its c-ketoacid, a-ketoisocaproate, reduces muscle proteolysis in vitro [25] and nitrogen excretion in vivo [36] . Alternatively, BCAA catabolism and muscle protein breakdown may be a coordinated response to acidosis and other catabolic conditions. Low protein diets supplemented with essential amino acids or a-ketoacids are being used increasingly in the conservative treatment of uremic patients. It also has been suggested that BCAA can be useful in treating patients with catabolic conditions [37] . For this reason, it is important to identify factors which might lower the efficiency by which BCAA or their a-ketoacids are utilized. One factor is chronic metabolic acidosis. It should be emphasized that in the present study, the degree of acidosis causing excessive BCAA catabolism was not severe (average bicarbonate, 19 1 mEq/liter). Correction of acidosis should be a goal of therapy, especially when treatment consists of limiting quantities of BCAA or branched-chain ketoacids given with low protein diets.
